Our hemp varieties are rich in CBD and CBG, and we strive to produce and offer select plants whose active ingredients meet the highest standards. These active ingredients are suitable for use in alternative medical products, as additives in cosmetics, and for refining into food products or as a tobacco substitute.
In addition, we offer high-quality products from first-rate European and American partners.
In medicine, CBD is primarily considered of interest for the treatment of cancer, chronic pain and neurogenic diseases such as Alzheimer's and Parkinson's. It also acts as an anti-inflammatory, a pain-reliever and, in contrast to THC, is not psychoactive.
Our plants contain high levels of CBG. This enables us to be one of the world's leading suppliers of this active ingredient and a strong partner to the pharmaceutical industry, amongst others. Studies increasingly show that this non-psychoactive substance can be widely used in a variety of ways such as for pain relief, cancer therapy and multiple sclerosis treatments.
This cannabinoid is psychoactive, and because the consumption of THC makes consumers "high", it remains strictly regulated by law in many countries. Without exception, our products contain a very low concentration of THC, always meeting the specific legal requirements, whether for the Swiss market or for those abroad.
For more information about our comprehensive range of quality products, please contact us.